PROSPECTIVE EVALUATION OF SERUM VITAMIN D LEVELS IN TYPE 2 DIABETES MELLITUS PATIENTS AND CORRELATION WITH GLYCEMIC CONTROL
Main Article Content
Keywords
Type 2 Diabetes Mellitus, Vitamin D, HbA1c, Glycemic Control, Biochemistry
Abstract
Background: Type 2 Diabetes Mellitus (T2DM) is a growing global health concern. Recent evidence suggests a potential link between Vitamin D deficiency and poor glycemic control. This study aimed to evaluate serum Vitamin D levels in T2DM patients and analyze their correlation with glycemic parameters.
Methods: This prospective observational study was conducted in the Department of Biochemistry, FH Medical College, Agra over 12 months. A total of 150 diagnosed T2DM patients were included. Serum 25(OH) Vitamin D and glycemic parameters (HbA1c, Fasting Blood Glucose [FBG], Postprandial Blood Glucose [PPBG]) were measured and analyzed.
Results: Vitamin D deficiency (<20 ng/mL) was observed in 68% of patients. A statistically significant inverse correlation was found between serum Vitamin D levels and HbA1c (r = –0.42, p < 0.01). Similar trends were seen with FBG and PPBG.
Conclusion: Vitamin D deficiency is highly prevalent in T2DM patients and is significantly associated with poor glycemic control. Screening and supplementation of Vitamin D may serve as an adjunct in the management of T2DM.
References
2. Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, et al. Prevalence of diabetes and prediabetes in 15 states of India: Results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5(8):585–96.
3. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 2003;17(3):509–11.
4. Bansal AS, Kaur H, Bansal S. Correlation between 25(OH)D levels and HbA1c in North Indian type 2 diabetic subjects. J Clin Diagn Res. 2014;8(2):30–3.
5. Palomer X, González-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10(3):185–97.
6. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr. 2004;79(5):820–5.
7. American Diabetes Association. Standards of medical care in diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S1–212.
8. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.
9. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20(11):1807–20.
10. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6):2017–29.
11. Boucher BJ. Is vitamin D status relevant to metabolic syndrome? Dermatoendocrinol. 2012;4(2):212–24.
12. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance. Diabetes. 2008;57(10):2619–25.
13. George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med. 2012;29(8):e142–50.
14. Seida JC, Mitri J, Colmers IN, Majumdar SR, Davidson MB, Edwards AL, et al. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99(10):3551–60.